267 related articles for article (PubMed ID: 36125818)
1. Targeted Therapies in Patients with Pulmonary Arterial Hypertension Due to Congenital Heart Disease.
Mares A; Mukherjee D; Lange RA; Nickel NP
Curr Vasc Pharmacol; 2022; 20(4):341-360. PubMed ID: 36125818
[TBL] [Abstract][Full Text] [Related]
2. Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease.
Luna-Lopez R; Segura de la Cal T; Sarnago Cebada F; Martin de Miguel I; Hinojosa W; Cruz-Utrilla A; Velazquez MT; Delgado JF; Mendoza A; Arribas Ynsaurriaga F; Escribano-Subías P
Heart; 2024 Feb; 110(5):346-352. PubMed ID: 37903556
[TBL] [Abstract][Full Text] [Related]
3. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
4. Pulmonary vasodilators can lead to various complications in pulmonary "arterial" hypertension associated with congenital heart disease.
Chida-Nagai A; Sagawa K; Tsujioka T; Fujimoto T; Taniguchi K; Sasaki O; Izumi G; Yamazawa H; Masaki N; Manabe A; Takeda A
Heart Vessels; 2020 Sep; 35(9):1307-1315. PubMed ID: 32285188
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.
Ruopp NF; Cockrill BA
JAMA; 2022 Apr; 327(14):1379-1391. PubMed ID: 35412560
[TBL] [Abstract][Full Text] [Related]
6. [Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].
Kaemmerer H; Gorenflo M; Hoeper M; Huscher D; Ewert P; Pittrow D
Dtsch Med Wochenschr; 2013 Jun; 138(23):1247-52. PubMed ID: 23720182
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and Management of Pulmonary Arterial Hypertension in Congenital Heart Disease.
Arshad HB; Duarte VE
Methodist Debakey Cardiovasc J; 2021; 17(2):145-151. PubMed ID: 34326934
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary arterial hypertension in adults with congenital heart disease: distinct differences from other causes of pulmonary arterial hypertension and management implications.
Dimopoulos K; Giannakoulas G; Wort SJ; Gatzoulis MA
Curr Opin Cardiol; 2008 Nov; 23(6):545-54. PubMed ID: 18830068
[TBL] [Abstract][Full Text] [Related]
9. Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.
Galie N; Manes A; Palazzini M; Negro L; Marinelli A; Gambetti S; Mariucci E; Donti A; Branzi A; Picchio FM
Drugs; 2008; 68(8):1049-66. PubMed ID: 18484798
[TBL] [Abstract][Full Text] [Related]
10. Plasma Connective Tissue Growth Factor as a Biomarker of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Adults.
Liu W; Hua Y; Zheng D; Lv W; Zhang W; Chen Q; Huang R; Li X
Circ J; 2023 Mar; 87(4):527-535. PubMed ID: 36843115
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy in Congenital Heart Disease, Complicated by Pulmonary Arterial Hypertension-A Challenging Issue for the Pregnant Woman, the Foetus, and Healthcare Professionals.
Rudienė V; Kaplerienė L; Jančauskaitė D; Meškėnė E; Palevičiūtė E; Laukytė-Slėnienė M; Gasiūnaitė D; Ramašauskaitė D; Jurevičienė E; Gumbienė L
Medicina (Kaunas); 2022 Mar; 58(4):. PubMed ID: 35454315
[No Abstract] [Full Text] [Related]
12. Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study.
Beghetti M; Channick RN; Chin KM; Di Scala L; Gaine S; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Rubin LJ; Simonneau G; Sitbon O; Tapson VF; Galiè N
Eur J Heart Fail; 2019 Mar; 21(3):352-359. PubMed ID: 30632656
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary arterial hypertension in adult congenital heart disease.
Brida M; Gatzoulis MA
Heart; 2018 Oct; 104(19):1568-1574. PubMed ID: 29720395
[TBL] [Abstract][Full Text] [Related]
14. Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry.
Xie F; Quan R; Zhang G; Tian H; Chen Y; Yu Z; Zhang C; Liu Y; Zhu X; Wu W; Zhu X; Yang Z; Gu Q; Xiong C; Han H; Cheng Y; He J; Wu Y
J Heart Lung Transplant; 2023 Jul; 42(7):974-984. PubMed ID: 37002152
[TBL] [Abstract][Full Text] [Related]
15. Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: a qualitative systematic review.
Fine N; Dias B; Shoemaker G; Mehta S
Can J Cardiol; 2009 Mar; 25(3):e63-8. PubMed ID: 19279988
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension and congenital heart disease: An insight from the REHAP National Registry.
Alonso-Gonzalez R; Lopez-Guarch CJ; Subirana-Domenech MT; Ruíz JMO; González IO; Cubero JS; Del Cerro MJ; Salvador ML; Subira LD; Gallego P; Escribano-Subias P;
Int J Cardiol; 2015 Apr; 184():717-723. PubMed ID: 25781723
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of continuous prostacyclin therapy in adults with pulmonary hypertension associated with congenital heart disease.
Thomas IC; Glassner-Kolmin C; Gomberg-Maitland M
Int J Cardiol; 2013 Oct; 168(4):4117-21. PubMed ID: 23890862
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary Hypertension and Congenital Heart Disease.
Roth TS; Aboulhosn JA
Cardiol Clin; 2016 Aug; 34(3):391-400. PubMed ID: 27443136
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary hypertension related to congenital heart disease: a call for action.
Dimopoulos K; Wort SJ; Gatzoulis MA
Eur Heart J; 2014 Mar; 35(11):691-700. PubMed ID: 24168793
[TBL] [Abstract][Full Text] [Related]
20. Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentan.
Schuuring MJ; Vis JC; Duffels MG; Bouma BJ; Mulder BJ
Ther Clin Risk Manag; 2010 Sep; 6():359-66. PubMed ID: 20856682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
